Vor Biopharma: Funding, Investors & Team (Oct 2026)
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
Vor Biopharma has raised $571M across 5 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Mar 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vor Biopharma Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Vor Biopharma Funding Rounds
Vor Biopharma raised $116M in an undisclosed round announced in Dec 2022.
2 years later, an undisclosed round of $55.6M was announced in Dec 2024.
6 months later, an undisclosed round of $175M was announced in Jun 2025.
6 months later, an undisclosed round of $150M was announced in Dec 2025.
3 months later, an undisclosed round of $75.0M was announced in Mar 2026.
Vor Biopharma Founders and Leadership Team
Contact details for the Vor Biopharma team: 1 has a LinkedIn profile.
Start 14-day free trial →Vor Biopharma Funding Compared to Other Biotechnology Startups
Vor Biopharma's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vor Biopharma in Biotechnology and Cambridge
Companies Similar to Vor Biopharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Vor Biopharma Funding FAQs
What does Vor Biopharma do?
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
How much funding has Vor Biopharma raised?
Vor Biopharma has raised $571M across 5 rounds on record. The most recent is an undisclosed round of $75.0M announced in Mar 2026.
When did Vor Biopharma last raise funding?
Vor Biopharma's most recent funding round on record is an undisclosed round of $75.0M, announced in Mar 2026.
Who founded Vor Biopharma?
FundedIQ lists Jean Paul Kress (Founder), Siddhartha Mukherjee (Founder) at Vor Biopharma.
Where is Vor Biopharma headquartered?
Vor Biopharma is based in Cambridge, Massachusetts, United States.
How many employees does Vor Biopharma have?
Vor Biopharma is in the 101-250 employee band.
How does Vor Biopharma's funding compare to other Biotechnology startups?
Vor Biopharma's latest round of $75.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vor Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vor Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.